YMRC
LMAT icon

Yorktown Management & Research Company’s LeMaitre Vascular LMAT Stock Holding History

Yorktown Management & Research Company’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8,500
Closed -$285K – 356
2018
Q2 		$285K Hold
8,500
– – 0.08% 290
2018
Q1 		$308K Buy
8,500
+1,675
+25% +$58K 0.09% 260
2017
Q4 		$217K Hold
6,825
– – 0.06% 359
2017
Q3 		$255K Buy
+6,825
New +$232K 0.07% 308

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Yorktown Management & Research Company's LMAT Position: Q3 2018 in Review

Yorktown Management & Research Company sold out of LeMaitre Vascular (LMAT) in Q3 2018, closing a stake of 8,500 shares — an estimated $285K sold.

Yorktown Management & Research Company first reported a position in LMAT in Q3 2017 and held it in 4 quarters. The position peaked at $308K in Q1 2018. 156 funds tracked by Wall St. Rank hold LMAT as of Q3 2018.

  • Yorktown Management & Research Company reported no remaining LeMaitre Vascular position as of Q3 2018 after selling out during the quarter.
  • Yorktown Management & Research Company sold 8,500 LeMaitre Vascular shares in Q3 2018, an estimated $285K.
  • Yorktown Management & Research Company first reported a position in LeMaitre Vascular in Q3 2017 and held it in 4 quarters.
  • Yorktown Management & Research Company's LeMaitre Vascular position peaked at $308K in Q1 2018.
  • 156 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2018.

Based on Yorktown Management & Research Company's 13F filing for Q3 2018, filed 8 Nov 2018.